Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Authors
Keywords
COVID-19, SARS-CoV-2, Terpenes, Computer aided drug design and discovery
Journal
JOURNAL OF MOLECULAR LIQUIDS
Volume 320, Issue -, Pages 114493
Publisher
Elsevier BV
Online
2020-10-07
DOI
10.1016/j.molliq.2020.114493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach
- (2020) Ziyad Tariq Muhseen et al. MOLECULES
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
- (2020) Davide Gentile et al. Marine Drugs
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient
- (2020) Emily Hillaker et al. PHARMACOTHERAPY
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
- (2020) Ruiyun Li et al. SCIENCE
- A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
- (2020) Donald C. Hall et al. Travel Medicine and Infectious Disease
- Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
- (2020) Yu-chen Cao et al. Travel Medicine and Infectious Disease
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
- (2020) Mubarak A. Alamri et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach
- (2020) Syed Ovais Aftab et al. Journal of Translational Medicine
- Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
- (2020) Mirza S. Baig et al. DRUGS IN R&D
- Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
- (2020) Shweta Choudhary et al. Frontiers in Immunology
- Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
- (2020) Muhammad Usman Mirza et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
- (2020) Muhammad Usman Mirza et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
- (2019) Aldenor G. Santos et al. Scientific Reports
- Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
- (2019) Muhammad Tahir ul Qamar et al. Journal of Translational Medicine
- Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease
- (2018) Harvijay Singh et al. BIOCHIMIE
- Perspectives towards antiviral drug discovery against Ebola virus
- (2018) Muhammad Usman Mirza et al. JOURNAL OF MEDICAL VIROLOGY
- Glycan-dependent chikungunya viral infection divulged by antiviral activity of NAG specific chi-like lectin
- (2018) Ramanjit Kaur et al. VIROLOGY
- Molecular docking and in silico ADMET studies of silibinin and glycyrrhetic acid anti-inflammatory activity
- (2017) Arif Malik et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- MPD3: a useful medicinal plants database for drug designing
- (2016) Arooj Mumtaz et al. NATURAL PRODUCT RESEARCH
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Inhibition of chikungunya virus by picolinate that targets viral capsid protein
- (2016) Rajesh Sharma et al. VIROLOGY
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
- (2014) Rashmi Kumari et al. Journal of Chemical Information and Modeling
- Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
- (2013) A. O. Adedeji et al. JOURNAL OF VIROLOGY
- Molecular Dynamics Investigation on a Series of HIV Protease Inhibitors: Assessing the Performance of MM-PBSA and MM-GBSA Approaches
- (2012) Hemant Kumar Srivastava et al. Journal of Chemical Information and Modeling
- NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database
- (2012) Manu Mangal et al. NUCLEIC ACIDS RESEARCH
- Automation of the Charmm General Force Field for Drug-Like Molecules
- (2011) Kenno Vanommeslaeghe et al. BIOPHYSICAL JOURNAL
- Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis
- (2011) Xiu-ying Xiao et al. CANCER LETTERS
- Virtual screening using molecular simulations
- (2011) Tianyi Yang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
- (2010) Tingjun Hou et al. Journal of Chemical Information and Modeling
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- CHARMM: The biomolecular simulation program
- (2009) B. R. Brooks et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
- (2009) K. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started